Opthea Presents Positive Data from OPT-302 Phase 2b Wet AMD Trial at EURETINA Congress

    NEXT STORY
    Novavax to Present at the H.C. Wainwright 21st Annual Global Investment Conference
    PREV STORY
    Biomarkers Research Report, 2019: Worldwide Technologies, Markets & 302 Company Profiles (2018-2028)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Aduro Biotech Announces Fourth Quarter and Full Year 2016 Financial Results

    -Progress in 2016 Has Positioned the Company to Have Six Agents in the Clinic ...

    author_avatar
    NASDAQ Market News

    Calithera Biosciences Announces CB-839 in Combination with Nivolumab Phase 1/2 Data Accepted for Oral Presentation at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting

    SOUTH SAN FRANCISCO, Calif., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), ...

    author_avatar
    NASDAQ Market News

    Argos Therapeutics to Host Second Quarter 2016 Financial Results Conference Call on Wednesday, August 10, 2016

    DURHAM, N.C., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an ...

    author_avatar
    NASDAQ Market News